NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.00
+0.25 (3.23%)
At close: Apr 2, 2026, 4:00 PM EDT
7.77
-0.23 (-2.88%)
After-hours: Apr 2, 2026, 5:02 PM EDT
NeoGenomics Market Cap
NeoGenomics has a market cap or net worth of $1.04 billion as of April 2, 2026. Its market cap has decreased by -18.75% in one year.
Market Cap
1.04B
Enterprise Value
1.29B
1-Year Change
-18.75%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.04B, an increase of 13,045.54%. That is a compound annual growth rate of 24.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.04B | -31.75% |
| Dec 31, 2025 | 1.52B | -28.07% |
| Dec 31, 2024 | 2.12B | 2.57% |
| Dec 29, 2023 | 2.06B | 76.73% |
| Dec 30, 2022 | 1.17B | -72.22% |
| Dec 31, 2021 | 4.20B | -29.72% |
| Dec 31, 2020 | 5.98B | 95.74% |
| Dec 31, 2019 | 3.05B | 160.37% |
| Dec 31, 2018 | 1.17B | 64.64% |
| Dec 29, 2017 | 712.40M | 5.87% |
| Dec 30, 2016 | 672.90M | 41.66% |
| Dec 31, 2015 | 475.00M | 89.92% |
| Dec 31, 2014 | 250.10M | 41.06% |
| Dec 31, 2013 | 177.30M | 57.88% |
| Dec 31, 2012 | 112.30M | 85.62% |
| Dec 30, 2011 | 60.50M | 24.49% |
| Dec 31, 2010 | 48.60M | -12.90% |
| Dec 31, 2009 | 55.80M | 189.12% |
| Dec 31, 2008 | 19.30M | -43.07% |
| Dec 31, 2007 | 33.90M | -16.30% |
| Dec 29, 2006 | 40.50M | 841.86% |
| Dec 30, 2005 | 4.30M | -20.37% |
| Dec 31, 2004 | 5.40M | -31.65% |
| Mar 16, 2004 | 7.90M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 2.95B |
| Veracyte | 2.53B |
| GRAIL | 2.16B |
| GeneDx Holdings | 1.89B |
| CareDx | 892.70M |
| OPKO Health | 853.95M |
| Castle Biosciences | 731.39M |
| Personalis | 660.23M |